TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Cryogenetics AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,835
|
3,637
|
2,962 |
| Financial expenses |
139
|
96
|
89 |
| Earnings before taxes |
-499
|
763
|
348 |
| Total assets |
4,513
|
4,643
|
4,192 |
| Current assets |
1,220
|
2,337
|
2,222 |
| Current liabilities |
825
|
778
|
915 |
| Equity capital |
2,881
|
2,846
|
2,283 |
| - share capital |
374
|
394
|
421 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
63.8%
|
61.3%
|
54.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-17.6%
|
21.0%
|
11.7% |
| Return on assets (ROA) |
-8.0%
|
18.5%
|
10.4% |
| Current ratio |
147.9%
|
300.4%
|
242.8% |
| Return on equity (ROE) |
-17.3%
|
26.8%
|
15.2% |
| Change turnover | |||
| Change turnover % |
31%
|
9% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.